XTalks

JANUARY 12, 2022

Chan School of Public Health and Nanyang Technological University (NTU) Singapore recently unveiled a biodegradable, waterproof and antibacterial food packaging. The “smart” packaging kills harmful microbes and can extend the shelf life of fresh foods for multiple days. So, how does it work? Coli or Listeria. percent in the same year.

Packaging 98

Packaging Packaging Scientist Bacteria 98

Pharmaceutical Technology

MARCH 10, 2023

Pharmaceutical and biotechnology industries widely use freeze-drying systems to protect vaccines, antibodies, antibiotics such as penicillin, blood plasma, proteins, enzymes, hormones, viruses, and bacteria from heat and minimise their biological activity.

Manufacturing 147

Manufacturing Production Containment Antibody 147

XTalks

FEBRUARY 11, 2021

The Hershey-Chase experiment is the historic study that solidified DNA as the carrier of genetic information over protein. At the same time, it was thought that protein was the carrier of genetic information as DNA was too inert of a substance — and was also shielded away in the nucleus — to be able to harbor such a role. Martha Chase.

Genetics 119

Genetics DNA Genome Genomics 119

Drug Discovery World

MAY 2, 2023

In the event of an attack from similar bacteriophages, the bacteria can recognise these segments and use this to discern and cleave the viral DNA, which disrupts the viral gene function. This indicates that an efficient anti-cancer therapy must inhibit the activity of the proteins expressed by these genes.

Genome 52

Genome Genomics Gene DNA 52

XTalks

FEBRUARY 11, 2021

The drugmaker is targeting various steps in the manufacturing process, beginning right at the DNA stage, which is required as the template from which the mRNA for the SARS-CoV-2 spike protein in the vaccine is made. coli bacteria. The bacteria are grown in large vats, with the process taking two weeks.

Manufacturing 52

Manufacturing Vaccination Vaccine DNA 52

XTalks

AUGUST 2, 2023

2) Paxlovid (nirmatrelvir/ritonavir) Paxlovid is a dual-packaged oral medication for the treatment of COVID-19. It contains the antiviral medications nirmatrelvir and ritonavir. The monoclonal antibody targets CD20, a protein found on the surface of B lymphocytes (B cells). billion in 2022, a 6.45 percent increase from the $9.13

Sales 98

Sales Manufacturing FDA Approval Life Science 98